Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

被引：0
|
作者：
Do Hyoung Lim
Young Suk Park
Byeong-Bae Park
Sang Hoon Ji
Jeeyun Lee
Keon Woo Park
Jung Hoon Kang
Se-Hoon Lee
Joon Oh Park
Kihyun Kim
Won Seog Kim
Chul Won Jung
Young-Hyuck Im
Won Ki Kang
Keunchil Park
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 56卷
关键词：
Capecitabine; Mitomycin-C; Advanced colorectal cancer; Third-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 14
页数：4
相关论文
共 50 条
  • [1] Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study
    Lim, DH
    Park, YS
    Park, BB
    Ji, SH
    Lee, J
    Park, KW
    Kang, JH
    Lee, SH
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Im, YH
    Kang, WK
    Park, K
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (01) : 10 - 14
  • [2] A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer
    Kim, Jung Han
    Kim, Hyeong Su
    Choi, Dae Ro
    Jang, Geundoo
    Kwon, Jung Hye
    Kim, Ho Young
    Jung, Joo Young
    Kim, Hyo Jung
    Song, Hun Ho
    Shin, Yun Ho
    Jung, So Young
    Kim, Byung Chun
    Zang, Dae Young
    [J]. ONCOLOGY LETTERS, 2011, 2 (06) : 1253 - 1256
  • [3] Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer
    Scartozzi, Mario
    Falcone, Alfredo
    Pucci, Francesca
    Braconi, Chiara
    Pierantoni, Chiara
    Cavanna, Luigi
    Franciosi, Vittorio
    Berardi, Rossana
    Berettas, Giordano
    Masi, Gianluca
    Allegrini, Giacomo
    Zaniboni, Alberto
    Labianca, Roberto
    Cascinu, Stefano
    [J]. TUMORI JOURNAL, 2006, 92 (05): : 384 - 388
  • [4] Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer
    Scartozzi, M.
    Falcone, A.
    Pucci, F.
    Braconi, C.
    Cavanna, L.
    Franciosi, V.
    Berardi, R.
    Beretta, G. D.
    Masi, G. L.
    Allegrini, G.
    Zaniboni, A.
    Labianca, R.
    Cascinu, S.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 149 - 149
  • [5] Capecitabine in combination with mitomycin C as third line chemotherapy in patients with advanced colorectal cancer
    Ritorto, G.
    Fanchini, L.
    Racca, P.
    Evangelista, W.
    Volpatto, R.
    Angelini, F.
    Ciuffreda, L.
    Ottaviani, D.
    Bertetto, O.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 46 - 46
  • [6] A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer
    Choi, Dae Ro
    Yoon, Sang Nam
    Kim, Hyeong Su
    Kim, Jung Han
    Kim, Kwang Yong
    Kim, Byung Chun
    Choi, Young Kyun
    Kim, Jin Bae
    Han, Boram
    Song, Hun Ho
    Zang, Dae Young
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 639 - 643
  • [7] A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer
    Dae Ro Choi
    Sang Nam Yoon
    Hyeong Su Kim
    Jung Han Kim
    Kwang Yong Kim
    Byung Chun Kim
    Young Kyun Choi
    Jin Bae Kim
    Boram Han
    Hun Ho Song
    Dae Young Zang
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 639 - 643
  • [8] Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer
    S Rao
    D Cunningham
    T Price
    M E Hill
    P J Ross
    N Tebbutt
    A R Norman
    J Oates
    P Shellito
    [J]. British Journal of Cancer, 2004, 91 : 839 - 843
  • [9] Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer
    Rao, S
    Cunningham, D
    Price, T
    Hill, ME
    Ross, PJ
    Tebbutt, N
    Norman, AR
    Oates, J
    Shellito, P
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (05) : 839 - 843
  • [10] PHASE II STUDY OF OXALIPLATIN AS THIRD-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Sikder, S. K.
    Rahman, M.
    Saha, R. K.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 219 - 219
12345